CSL begins Covid vaccine manufacture in Melbourne today
CSL will begin manufacturing the University of Oxford/AstraZeneca AZD1222 Covid-19 vaccine candidate at its advanced manufacturing facility in Broadmeadows in northern Melbourne today. The high-tech biotechnology plant (pictured) is contracted to AstraZeneca and the Australian Government to manufacture approximately 30 million doses of the AZD1222 vaccine candidate. In a statement the company said first doses…
Details